Invex Therapeutics Asks for Trading Halt Ahead of Acquisition and Capital Raise News
Invex Therapeutics Ltd has requested a trading halt until it announces a material acquisition and a capital raising, Reuters reports.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Invex Therapeutics Ltd has asked for its shares to be halted from trading, according to a Reuters report based on the company's filing. The company said the halt is pending an announcement about a material acquisition and a capital raising.
The filing does not give details on the size of the deal, the terms of the fundraising, or when trading will resume.
why it matters
A trading halt is usually requested so that all market participants receive important information at the same time and no one trades without it. For minority shareholders, such events often signal significant changes to a company's structure, so it is worth waiting for the official terms.
tags
instruments
sources
- Invex Therapeutics Requests Trading Halt — Reuters, 22 October 2026 at 01:33 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗